Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure.American Journal of Transplantation2019
2018 Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantationAmerican Journal of Transplantation.  18:2189-2199. 2018
2017 Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: A Midwest pediatric nephrology consortium studyHealth and Quality of Life Outcomes.  15. 2017
2017 Polyomavirus reactivation and immune responses to kidney-specific self-antigens in transplantationJournal of the American Society of Nephrology.  28:1314-1325. 2017
2016 Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: A Midwest Pediatric Nephrology Consortium studyPediatric Transplantation.  20:378-387. 2016
2016 Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium studyPediatric Nephrology.  31:465-472. 2016
2016 Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney diseaseKidney International.  89:1231-1243. 2016
2016 The kidney-vascular-bone axis in the chronic kidney disease-mineral bone disorderTransplantation.  100:497-505. 2016
2015 The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium studyPediatric Nephrology.  30:1467-1476. 2015
2015 Pathophysiology of the chronic kidney disease - Mineral bone disorderCurrent Opinion in Nephrology and Hypertension.  24:303-309. 2015
2015 Kidney transplant results in children: Progress made, but blacks lag behindKidney International.  87:492-494. 2015
2015 Modernization of Chronic Allograft Injury Research: Better Biomarkers, Better Studies, Better Outcomes.Clinical Transplants.  31:211-225. 2015
2014 CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorderJournal of the American Society of Nephrology.  25:1760-1773. 2014
2014 Cytomegalovirus and anemia: Not just for transplant anymoreJournal of the American Society of Nephrology.  25:1613-1615. 2014
2014 Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney diseaseAmerican Journal of Nephrology.  39:392-399. 2014
2013 Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney diseaseAmerican Journal of Nephrology.  38:158-167. 2013
2013 VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipientsThe Journal of heart transplantation.  32:120-128. 2013
2012 Azithromycin decolonization of STECĝ€"a new risk emergesNature Reviews Nephrology.  8:429. 2012
2012 Therapy: Azithromycin and decolonization after HUSNature Reviews Nephrology.  8:317-318. 2012
2012 Second trimester anti-angiogenic proteins and preeclampsiaPregnancy Hypertension.  2:158-163. 2012
2010 Hyponatremia is Associated with Increased Severity of Disease in Critically Ill Children with BronchiolitisInternational Journal of Clinical Medicine.  01:37-40. 2010
2009 Acquired coarctation of the abdominal aorta related to umbilical artery catheterizationConnecticut Medicine.  73:273-276. 2009
2009 Hypokalemia and nocturia in a 15-year-old girlClinical Pediatrics.  48:317-319. 2009
2000 One-stage Soave pull-through for Hirschsprung's disease: A comparison of the transanal and open approachesJournal of Pediatric Surgery.  35:820-822. 2000

Chapter

Year Title Altmetric
2014 Disorders of Mineral and Bone Metabolism in Chronic Kidney Disease.  320-331. 2014
2013 Pathophysiology of Chronic Kidney Disease Mineral Bone Disorder (CKD-MBD).  632-639. 2013

Investigator On

  • APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by Genentech 2018 - 2021
  • Private Grant  awarded by Sanofi US Services Inc 2017 - 2021
  • The Child-Centered Outcomes in Practice and Research (COPR) Center of Excellence: Strengthing the Clinical Validity Evidence Base for PROMIS Measures in Chronically Ill Children  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2015 - 2019
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2016 - 2019
  • Chronic Kidney Disease in Children CKID IV  awarded by CHILDREN'S MERCY HOSPITAL 2018 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2019
  • Private Grant  awarded by VIFOR 2016 - 2019
  • Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury  awarded by CINCINNATI CHILDREN'S HOSPITAL 2015 - 2019
  • Private Grant  awarded by OCTAPHARMA - NEW 2016 - 2019
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL 2015 - 2018
  • Chronic Kidney Disease in Children (CKiD III)  awarded by CHILDREN'S MERCY HOSPITAL 2013 - 2018
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2018
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2016 - 2017
  • International Pediatric Peritoneal Biopsy Study in Children  awarded by UNIVERSITY OF HEIDELBERG 2015 - 2016
  • Education And Training

  • Doctor of Medicine, University of Connecticut 2004
  • University of Connecticut, Residency 2007
  • Boston Children's Hospital, Postdoctoral Fellowship 2010
  • Full Name

  • Michael Seifert